Syros to Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, March 27, 2024
Syros Pharmaceuticals (SYRS) to report Q4 and full year 2023 financial results and host conference call on March 27, 2024.
03/20/2024 - 07:00 AM
CAMBRIDGE, Mass. --(BUSINESS WIRE)--
Syros Pharmaceuticals (NASDAQ:SYRS), a biopharmaceutical company committed to advancing new standards of care for the frontline treatment of hematologic malignancies, today announced that it will host a live conference call and webcast at 8:30 a.m. ET on Wednesday, March 27, 2024 to report its fourth quarter and full year 2023 financial results and provide a corporate update.
To access the live conference call, please dial (888) 259-6580 (domestic) or (416) 764-8624 (international) and refer to conference ID 21905455. A webcast of the call will also be available on the Investors & Media section of the Syros website at www.syros.com . An archived replay of the webcast will be available for approximately 30 days following the call.
About Syros Pharmaceuticals
Syros is committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies. Driven by the motivation to help patients with blood disorders that have largely eluded other targeted approaches, Syros is developing tamibarotene, an oral selective RARα agonist in frontline patients with higher-risk myelodysplastic syndrome and acute myeloid leukemia with RARA gene overexpression. For more information, visit www.syros.com and follow us on Twitter (@SyrosPharma ) and LinkedIn .
View source version on businesswire.com: https://www.businesswire.com/news/home/20240320845080/en/
Syros
khunady@syros.com
Investors
hannah.deresiewicz@sternir.com
Source: Syros Pharmaceuticals
When will Syros Pharmaceuticals report its Q4 and full year 2023 financial results?
Syros Pharmaceuticals will report its Q4 and full year 2023 financial results on March 27, 2024.
What time will the live conference call and webcast take place?
The live conference call and webcast will take place at 8:30 a.m. ET on March 27, 2024.
How can I access the live conference call?
To access the live conference call, dial (888) 259-6580 (domestic) or (416) 764-8624 (international) and refer to conference ID 21905455.
Where can I find the webcast of the call?
The webcast of the call will be available on the Investors & Media section of the Syros website at www.syros.com.
How long will the archived replay of the webcast be available?
The archived replay of the webcast will be available for approximately 30 days following the call.
Syros Pharmaceuticals Inc.
SYRS Rankings
#4660 Ranked by Stock Gains
SYRS Stock Data
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Tags
Health Technology, Biotechnology, Manufacturing, Pharmaceutical Preparation Manufacturing
Country
US
City
Cambridge
About SYRS
syros pharmaceuticals is a life sciences company that is focused on treating disease by mapping gene regulatory circuits and modulating the factors that regulate gene expression. syros has pioneered world-leading gene control research and drug discovery capabilities with a proven ability to integrate disease biology and genomic data--a proficiency that is not well represented in pharmaceutical r&d. central to the syros approach is a proprietary platform of carefully integrated assay technologies, bioinformatics, and biologic insights developed by members of syros' senior leadership. while this scientific approach has applications in many therapeutic areas, syros has demonstrated success initially in oncology, where it may help address numerous unmet medical needs.
